1. FIL‐PTCL13: PHASE IB/II STUDY OF ROMIDEPSIN/CHOEP FOLLOWED BY HIGH‐DOSE CHEMOTHERAPY AND TRANSPLANTATION IN UNTREATED PERIPHERAL T‐CELL LYMPHOMAS. (June 2017) Authors: Chiappella, A.; Carniti, C.; Ceccarelli, M.; Cabras, M.G.; Re, A.; Salvi, F.; Santoro, A.; Stefoni, V.; Pileri, S.; Ciccone, G.; Corradini, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PHASE II FIL‐PTCL13 STUDY OF ROMIDEPSIN‐CHOEP FOLLOWED BY HIGH‐DOSE CHEMOTHERAPY AND TRANSPLANTATION IN UNTREATED PERIPHERAL T‐CELL LYMPHOMAS. (12th June 2019) Authors: Chiappella, A.; Carniti, C.; Evangelista, A.; Re, A.; Cabras, M.G.; Stefoni, V.; Castellino, C.; Congiu, A.G.; Pinto, A.; Zanni, M.; Rusconi, C.; Molinari, A.L.; Ciancia, R.; Baldini, L.; Nassi, L.; Re, F.; Tani, M.; Ilariucci, F.; Cavallo, F.; Santoro, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LONG‐TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT). (12th June 2019) Authors: Ferreri, A.J.; Sassone, M.C.; Angelillo, P.; Zaja, F.; Re, A.; Spina, M.; Di Rocco, A.; Fabbri, A.; Stelitano, C.; Frezzato, M.; Rusconi, C.; Zambello, R.; Arcari, A.; Bertoldero, G.; De Lorenzo, D.; Volpetti, S.; Calimeri, T.; Perrone, S.; Cecchetti, C.; Ciceri, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OUTCOMES IN FIRST RELAPSED‐REFRACTORY YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: RESULTS FROM THE MANTLE‐FIRST STUDY. (12th June 2019) Authors: Visco, C.; Di Rocco, A.; Tisi, M.C.; Morello, L.; Evangelista, A.; Zilioli, V.R.; Rusconi, C.; Hohaus, S.; Sciarra, R.; Re, A.; Tecchio, C.; Chiappella, A.; Marin‐Niebla, A.; McCulloch, R.; Gini, G.; Perrone, T.; Nassi, L.; Pennese, E.; Stefani, P.M.; Cox, M.C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FIRST SALVAGE TREATMENT WITH BENDAMUSTINE AND BRENTUXIMAB VEDOTIN IN HODGKIN LYMPHOMA: A PHASE 2 STUDY OF FIL ONLUS. (12th June 2019) Authors: Stefoni, V.; Broccoli, A.; Botto, B.; Corradini, P.; Pinto, A.; Re, A.; Vitolo, U.; Fanti, S.; Argnani, L.; Zinzani, P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. IBRUTINIB COMPARED TO STANDARD CHEMOTHERAPY FOR CENTRAL NERVOUS SYSTEM RECURRENCE OF MANTLE CELL LYMPHOMA. (12th June 2019) Authors: Rusconi, C.; Tucker, D.; Bernard, S.; Muzi, C.; Crucitti, L.; Stefani, P.; Cox, M.; Gini, G.; Re, A.; Sciarra, R.; Liberati, A.; Morello, L.; Arcari, A.; Mannina, D.; Vitagliano, O.; Sartori, R.; Chiappella, A.; Balzarotti, M.; Vitolo, U.; Thieblemont, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PO-1328 VMAT-SIB boost to the dominant intraprostatic lesion: preliminary results of a dose escalation trial. (August 2021) Authors: Bonome, P.; Macchia, G.; Ferro, M.; Cilla, S.; Romano, C.; Re, A.; Picardi, V.; Boccardi, M.; Pezzulla, D.; Cammelli, S.; Buwenge, M.; Tagliaferri, L.; Morganti, A.G.; Morganti, A.; Valentini, V.; Deodato, F. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1090 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PO-1394 Stereotactic body radiotherapy for prostate cancer lymph node metastases: a systematic review. (August 2021) Authors: Zamagni, A.; Bonetti, M.; Buwenge, M.; Ntreta, M.; Tolento, G.; Cammelli, S.; Donati, C.M.; Lodi Rizzini, E.; Boccardi, M.; Re, A.; Deodato, F.; Cilla, S.; Macchia, G.; Morganti, A.G. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PO-1392 Salvage radiotherapy of prostate cancer: a risk stratification system based on prognostic factors. (August 2021) Authors: Bisello, S.; Arcelli, A.; Deodato, F.; Dominsky, N.; Tarantino, G.; Ntreta, M.; Cilla, S.; Siepe, G.; Cavallini, L.; Pezzulla, D.; Alitto, A.R.; Re, A.; Cammelli, S.; Cortesi, A.; Romeo, A.; Frezza, G.P.; Morganti, A.G.; Macchia, G.; Buwenge, M. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PO-1380 Adjuvant radiotherapy of prostate cancer: a risk stratification system based on prognostic factors. (August 2021) Authors: Bisello, S.; Arcelli, A.; Deodato, F.; Dominsky, N.; Tarantino, G.; Ntreta, M.; Cilla, S.; Siepe, G.; Cavallini, L.; Pezzulla, D.; Alitto, A.R.; Re, A.; Cammelli, S.; Cortesi, A.; Romeo, A.; Frezza, G.P.; Morganti, A.G.; Macchia, G.; Buwenge, M. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗